CEVA heads into today's Q1 2026 earnings call with one of the clearest bull-side setups in the semiconductor space — a stock that has nearly doubled in a month and analysts scrambling to reprice it higher.
The analyst community has turned conspicuously bullish in the 24 hours before the print. UBS raised its target from $42 to $48, maintaining Buy. TD Cowen lifted its target dramatically from $24 to $45, also maintaining Buy. Oppenheimer moved from $30 to $42. Rosenblatt raised from $40 to $45. The lone hold is JPMorgan, which initiated coverage just last week at Neutral and nudged its target from $30 to $36 on the same day the others were moving higher. The consensus mean price target now stands at $43.13, against a last close of $37.08 — a roughly 16% implied return potential, though JPMorgan's $36 target sits below the current price. Four firms are unanimous on Buy; the debate is less about direction and more about magnitude.
The bull case rests on CEVA's growing royalty streams from automotive and connectivity markets, including potential upside from Apple's internal modem ramp and its expanding Neural Processing Unit franchise. Bears point to a history of declining licence fees — from $104.6 million in 2016 to $85.7 million in 2020 — and the company's single-segment structure, which limits diversification. Valuation is no longer cheap: the stock's P/E has expanded by roughly 23 points over the past month and the EV/EBITDA now runs at 37.5x, compressing slightly on recent price action but still elevated for a name whose earnings history includes an 11.4% post-print drop in February.
Options positioning reinforces the bullish tilt. The put/call ratio has collapsed to 0.12, well below its 20-day average of 0.22 and near the lower end of its 52-week range of 0.05–0.89. That signals options traders are not hedging into the event — they are positioning for continuation. Short interest, at 7.1% of the free float, is a real but not extreme level. Borrow availability is loose and the cost to borrow is just 0.69%, down 16% over the past week, suggesting no meaningful squeeze pressure and no aggressive new short-side conviction building into the report.
The earnings release will test whether the fundamental story — royalty growth, AI-edge traction, and operating leverage — can sustain a valuation that has repriced dramatically in under six weeks.
See the live data behind this article on ORTEX.
Open CEVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
